Micro Therapeutics Stock Climbs 17%
Bloomberg News
SAN CLEMENTE — Micro Therapeutics Inc. stock climbed 17% Tuesday after the maker of treatments for neurovascular and peripheral vascular diseases said it entered into a distribution alliance with Guidant Corp.
Guidant may invest as much as $10 million in Micro Therapeutics in the form of convertible debt, equity and a credit line.
Micro Therapeutics stock rose 94 cents a share to $6.44 on the Nasdaq market.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
